Introduction to the special issue on Ophthalmic Genetics: Vision in 2020
- PMID: 32864823
- PMCID: PMC8117941
- DOI: 10.1002/ajmg.c.31841
Introduction to the special issue on Ophthalmic Genetics: Vision in 2020
Abstract
In this special issue of the American Journal of Medical Genetics, Part C, we explore the ever-expanding field of Ophthalmic Genetics. The eye is unique among organs for its accessibility to physical examination, permitting exploration of every tissue by slit lamp microscopy, ophthalmoscopy, and imaging including color and autofluorescent photography, ultrasound, optical coherence tomography (OCT), electrophysiology, and adaptive optics confocal and scanning laser ophthalmoscopy. This accessibility permits a variety of surgical and nonsurgical treatments, including the first FDA-approved gene therapy, voretigene neparvovec-rzyl for RPE65-associated Leber Congenital Amaurosis. In this issue, we sought to provide a survey highlighting how heritable ophthalmic disorders are recognizable and accessible to clinical geneticists as well as ophthalmologists.
Keywords: introduction; ophthalmic genetics; special issue.
© 2020 Wiley Periodicals LLC.
Conflict of interest statement
CONFLICT OF INTEREST
None.
Similar articles
-
Perifoveal Chorioretinal Atrophy after Subretinal Voretigene Neparvovec-rzyl for RPE65-Mediated Leber Congenital Amaurosis.Ophthalmol Retina. 2022 Jan;6(1):58-64. doi: 10.1016/j.oret.2021.03.016. Epub 2021 Apr 8. Ophthalmol Retina. 2022. PMID: 33838313 Free PMC article.
-
Subretinal Injection of Voretigene Neparvovec-rzyl in a Patient With RPE65-Associated Leber's Congenital Amaurosis.Ophthalmic Surg Lasers Imaging Retina. 2019 Oct 1;50(10):661-663. doi: 10.3928/23258160-20191009-01. Ophthalmic Surg Lasers Imaging Retina. 2019. PMID: 31671202
-
Short term morphological rescue of the fovea after gene therapy with voretigene neparvovec.Acta Ophthalmol. 2022 May;100(3):e807-e812. doi: 10.1111/aos.14990. Epub 2021 Jul 21. Acta Ophthalmol. 2022. PMID: 34289237
-
Gene therapy and the adeno-associated virus in the treatment of genetic and acquired ophthalmic diseases in humans: Trials, future directions and safety considerations.Clin Exp Ophthalmol. 2019 May;47(4):521-536. doi: 10.1111/ceo.13416. Epub 2019 Jan 2. Clin Exp Ophthalmol. 2019. PMID: 30345694 Review.
-
Voretigene neparvovec-rzyl for treatment of RPE65-mediated inherited retinal diseases: a model for ocular gene therapy development.Expert Opin Biol Ther. 2020 Jun;20(6):565-578. doi: 10.1080/14712598.2020.1740676. Epub 2020 Mar 25. Expert Opin Biol Ther. 2020. PMID: 32149547 Review.
References
-
- Daich Varela M, Jani P, Zein WM, D'Souza P, Wolfe L, Chisholm J, … Hufnagel RB (2020a). The peroxisomal disorder spectrum and Heimler syndrome: Deep phenotyping and review of the literature. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 10.1002/ajmg.c.31823 - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical